Cor­rect­ed: Roche is not mov­ing for­ward with SQZ pro­gram, send­ing the biotech in­to strate­gic re­view

This sto­ry was cor­rect­ed to note that Roche has elect­ed not to take its op­tion on SQZ’s pro­gram. A pre­vi­ous ver­sion said that Roche and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.